These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 33579866)

  • 41. Interrupting sequence variants and age of onset in Huntington's disease: clinical implications and emerging therapies.
    Wright GEB; Black HF; Collins JA; Gall-Duncan T; Caron NS; Pearson CE; Hayden MR
    Lancet Neurol; 2020 Nov; 19(11):930-939. PubMed ID: 33098802
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Paradoxical delay in the onset of disease caused by super-long CAG repeat expansions in R6/2 mice.
    Morton AJ; Glynn D; Leavens W; Zheng Z; Faull RL; Skepper JN; Wight JM
    Neurobiol Dis; 2009 Mar; 33(3):331-41. PubMed ID: 19130884
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inherited CAG.CTG allele length is a major modifier of somatic mutation length variability in Huntington disease.
    Veitch NJ; Ennis M; McAbney JP; ; Shelbourne PF; Monckton DG
    DNA Repair (Amst); 2007 Jun; 6(6):789-96. PubMed ID: 17293170
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic Contributors to Intergenerational CAG Repeat Instability in Huntington's Disease Knock-In Mice.
    Neto JL; Lee JM; Afridi A; Gillis T; Guide JR; Dempsey S; Lager B; Alonso I; Wheeler VC; Pinto RM
    Genetics; 2017 Feb; 205(2):503-516. PubMed ID: 27913616
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Loss of TDP-43 promotes somatic CAG repeat expansion in Huntington's disease knock-in mice.
    Bai D; Zhu L; Jia Q; Duan X; Chen L; Wang X; Hou J; Jiang G; Yang S; Li S; Li XJ; Yin P
    Prog Neurobiol; 2023 Aug; 227():102484. PubMed ID: 37315918
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Length of Uninterrupted CAG, Independent of Polyglutamine Size, Results in Increased Somatic Instability, Hastening Onset of Huntington Disease.
    Wright GEB; Collins JA; Kay C; McDonald C; Dolzhenko E; Xia Q; Bečanović K; Drögemöller BI; Semaka A; Nguyen CM; Trost B; Richards F; Bijlsma EK; Squitieri F; Ross CJD; Scherer SW; Eberle MA; Yuen RKC; Hayden MR
    Am J Hum Genet; 2019 Jun; 104(6):1116-1126. PubMed ID: 31104771
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Counting CAG repeats in the Huntington's disease gene by restriction endonuclease EcoP15I cleavage.
    Möncke-Buchner E; Reich S; Mücke M; Reuter M; Messer W; Wanker EE; Krüger DH
    Nucleic Acids Res; 2002 Aug; 30(16):e83. PubMed ID: 12177311
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Somatic CAG Repeat Stability in a Transgenic Sheep Model of Huntington's Disease.
    Handley RR; Reid SJ; Burch Z; Jacobsen JC; Gillis T; Correia K; Rudiger SR; McLaughlin CJ; Bawden CS; MacDonald ME; Wheeler VC; Snell RG
    J Huntingtons Dis; 2024; 13(1):33-40. PubMed ID: 38393920
    [TBL] [Abstract][Full Text] [Related]  

  • 49. No association of the SCA1 (CAG)31 allele with Huntington's disease, myotonic dystrophy type 1 and spinocerebellar ataxia type 3.
    Hellenbroich Y; Kaulich M; Opitz S; Schwinger E; Zühlke C
    Psychiatr Genet; 2004 Jun; 14(2):61-3. PubMed ID: 15167689
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel allele-specific quantification methods reveal no effects of adult onset CAG repeats on HTT mRNA and protein levels.
    Shin A; Shin B; Shin JW; Kim KH; Atwal RS; Hope JM; Gillis T; Leszyk JD; Shaffer SA; Lee R; Kwak S; MacDonald ME; Gusella JF; Seong IS; Lee JM
    Hum Mol Genet; 2017 Apr; 26(7):1258-1267. PubMed ID: 28165127
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical and genetic analysis of 29 Brazilian patients with Huntington's disease-like phenotype.
    Rodrigues GR; Walker RH; Bader B; Danek A; Brice A; Cazeneuve C; Russaouen O; Lopes-Cendes I; Marques W; Tumas V
    Arq Neuropsiquiatr; 2011 Jun; 69(3):419-23. PubMed ID: 21755114
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Correlation of inter-locus polyglutamine toxicity with CAG•CTG triplet repeat expandability and flanking genomic DNA GC content.
    Nestor CE; Monckton DG
    PLoS One; 2011; 6(12):e28260. PubMed ID: 22163004
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CAG Repeat Not Polyglutamine Length Determines Timing of Huntington's Disease Onset.
    ;
    Cell; 2019 Aug; 178(4):887-900.e14. PubMed ID: 31398342
    [TBL] [Abstract][Full Text] [Related]  

  • 54. DNA Repair in Huntington's Disease and Spinocerebellar Ataxias: Somatic Instability and Alternative Hypotheses.
    Maiuri T; Hung CLK; Suart C; Begeja N; Barba-Bazan C; Peng Y; Savic N; Wong T; Truant R
    J Huntingtons Dis; 2021; 10(1):165-173. PubMed ID: 33579859
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Parent-of-origin differences of mutant HTT CAG repeat instability in Huntington's disease.
    Aziz NA; van Belzen MJ; Coops ID; Belfroid RD; Roos RA
    Eur J Med Genet; 2011; 54(4):e413-8. PubMed ID: 21540131
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intergenerational and striatal CAG repeat instability in Huntington's disease knock-in mice involve different DNA repair genes.
    Dragileva E; Hendricks A; Teed A; Gillis T; Lopez ET; Friedberg EC; Kucherlapati R; Edelmann W; Lunetta KL; MacDonald ME; Wheeler VC
    Neurobiol Dis; 2009 Jan; 33(1):37-47. PubMed ID: 18930147
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Huntington's disease as caused by 34 CAG repeats.
    Andrich J; Arning L; Wieczorek S; Kraus PH; Gold R; Saft C
    Mov Disord; 2008 Apr; 23(6):879-81. PubMed ID: 18307262
    [TBL] [Abstract][Full Text] [Related]  

  • 58. DNA instability in replicating Huntington's disease lymphoblasts.
    Cannella M; Maglione V; Martino T; Ragona G; Frati L; Li GM; Squitieri F
    BMC Med Genet; 2009 Feb; 10():11. PubMed ID: 19210789
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetic modifiers of Mendelian disease: Huntington's disease and the trinucleotide repeat disorders.
    Holmans PA; Massey TH; Jones L
    Hum Mol Genet; 2017 Oct; 26(R2):R83-R90. PubMed ID: 28977442
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Msh2 acts in medium-spiny striatal neurons as an enhancer of CAG instability and mutant huntingtin phenotypes in Huntington's disease knock-in mice.
    Kovalenko M; Dragileva E; St Claire J; Gillis T; Guide JR; New J; Dong H; Kucherlapati R; Kucherlapati MH; Ehrlich ME; Lee JM; Wheeler VC
    PLoS One; 2012; 7(9):e44273. PubMed ID: 22970194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.